Author

Linnea Aziz

An infusion center pharmacist in Bellingham, Washington, Linnea Aziz, PharmD, BCPS, BCOP, reviews every chemotherapy regimen before medications are prepared for patients. She worked as a clinical hospital pharmacist before specializing in oncology, with a focus on targeted therapies and adverse side effects. Aziz received a BS in Pharmaceutical Sciences from Concordia University Wisconsin and a PharmD from Albany College of Pharmacy and Health Sciences, maintaining her clinical practice alongside her professional certifications.

Methylene Blue for Cancer: Potential & Research Cancer
MRD Positive: What It Means and What to Do Next Tests
Akkermansia and Cancer: A Look at the Research Cancer
CAR T-Cell Therapy Death Rate: Insights and Risks Cancer
IRAEs: The Spectrum of Immune-Related Adverse Events Immunity
Is Trastuzumab Immunotherapy or Targeted Therapy?Cancer
What Are ALK Inhibitors and How Do They Work?Cancer
KRAS G12D: A Key Mutation in Cancer Development Cancer
NAD and Breast Cancer: Implications for Tumor Growth Cancer
What Is CTLA-4 and How Does It Fight Cancer?Cancer
MDM2 Inhibitor: Pivotal Advances in Fighting Cancer Cancer
AMG 510: How It Targets Cancers With the KRAS G12C Mutation Drugs
Amivantamab-Lazertinib: A Combination Lung Cancer Therapy Cancer
Desmoplastic Small Round Cell Tumor: Diagnosis and Therapeutics Cancer
EZH2 Inhibitors: How They Work and Their Use in Cancer Drugs
Prostate-Specific Membrane Antigen: Diagnosis & Therapy Cancer
Genmab Synaffix: Advancing ADC Potential in Oncology Cancer
Echinomycin: Anticancer Activity and Clinical Hurdles Cancer
ADC Linkers: Role, Types, and Impact on Cancer Therapy Cancer
Cisplatin DNA Damage: How It Works to Fight Cancer Cancer
Cdc7 Inhibitor: Targeting Cell Division in Cancer Drugs
KRAS-Mutant Pancreatic Cancer Explained Cancer
KRAS Inhibitor: Emerging Strategies for Cancer Therapy Cancer
Chlorin e6: Uses in Cancer Treatment and Night Vision Drugs
Does Chemotherapy Cross the Blood-Brain Barrier?Cancer
Cetuximab Mechanism of Action: Pathways in Cancer Therapy Drugs
Spermidine and Cancer: The Current Scientific Research Cancer
Should You Discontinue Immunotherapy for a Low Cortisol Level?Hormones
Dendritic Cell Therapy: How It Works and What to Expect Therapies
Is Tumor Necrosis Good or Bad? A Look at Its Dual Role Cancer